Evidence map›Paper›PMID 40189294›Full record

ArticleInternal medicine (Tokyo, Japan)2025

Idiopathic Interstitial Lung Disease with Positive Anti-Zo and Anti-Ro52/SSA1 Antibodies.

Mizuha Haraguchi Hashiguchi, Ryusuke Yoshimi, Takuya Ozawa, Masato Asaoka, Junko Kagyo, Yoshie Kawahara, Tetsuya Shiomi

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mizuha Haraguchi HashiguchiDepartment of Respiratory Medicine, Internal Medicine, Keiyu Hospital, Japan.
Ryusuke YoshimiDepartment of Respiratory Medicine, Internal Medicine, Keiyu Hospital, Japan.
Takuya OzawaDepartment of Respiratory Medicine, Internal Medicine, Keiyu Hospital, Japan.
Masato AsaokaDepartment of Respiratory Medicine, Internal Medicine, Keiyu Hospital, Japan.
Junko KagyoDepartment of Respiratory Medicine, Internal Medicine, Keiyu Hospital, Japan.
Yoshie KawaharaDepartment of Dermatology, Keiyu Hospital, Japan.
Tetsuya ShiomiDepartment of Respiratory Medicine, Internal Medicine, Keiyu Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 70-year-old male presented with infiltration, ground-glass opacities, and bronchiectasis on chest radiography, which indicated interstitial pneumonia. Clinical findings (thickening of the skin on the fingers, slight nail fold petechiae, and skin lesions resembling mechanic's hands) suggested early systemic sclerosis and/or polymyositis/dermatomyositis. However, anti-Scl-70, anti-centromere, and anti-aminoacyl tRNA synthetase (anti-ARS) antibodies were negative. Exertion-related oxygenation gradually worsened. Since the multiplex protein array confirmed anti-Zo and anti-Ro52/SSA1 antibody positivity, anti-ARS antibody syndrome was diagnosed and treated with steroids and immunosuppressive drugs. The patient was concurrently diagnosed with advanced colorectal cancer. Treating interstitial pneumonia first allowed for the subsequent treatment of colorectal cancer without worsening the condition.

Indexed as

Antibodies, AntinuclearAutoantibodiesIdiopathic Interstitial PneumoniasLung Diseases, InterstitialRibonucleoproteinsAgedColorectal NeoplasmsHumansMaleAntibodies, AntinuclearAutoantibodiesRibonucleoproteinsSS-A antibodiesanti-ARS antibody syndromeanti-Ro52/SSA1anti-Zo

Identifiers

PMID40189294
PMCPMC12589152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.